SEC Form 4 · accession 0001415889-15-001355
Cocrystal Pharma, Inc. · COCP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phillip Md Et Al Frost
Director · 10% Owner
Period of report
Apr 13, 2015
Accepted (ET)
Apr 15, 2015 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412486
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options (Right to buy)F1,F2 | $1.17 | Apr 13, 2015 | A | 350,000 | A | — | Apr 13, 2025 | Common Stock | 350,000 | 350,000 | D |
Explanation of responses
- F1The Securities vest in four equal annual increments with the first vesting date being one year from the Transaction Date.
- F2Not applicable